Articles from Cloud-Clone Corp. (CCC)
KATY, TX / ACCESS Newswire / June 22, 2026 / World Parkinson's Day, observed on April 11 annually, continuously raises public awareness of the health and public health burdens brought by Parkinson's disease and other brain disorders. At present, brain diseases such as neurodegenerative illnesses, stroke and traumatic brain injury have emerged as critical global public health challenges. Constrained by complicated pathogenic mechanisms, numerous drug targets and the special physiological structure of the blood-brain barrier, the research and development of innovative drugs for brain diseases have long been plagued by high investment and high risks. Against this industrial backdrop, preclinical Contract Research Organizations (CROs) capable of providing one-stop services ranging from disease model construction to comprehensive pharmacodynamic evaluation have become core pillars to speed up new drug development and resolve research bottlenecks.
By Cloud-Clone Corp. (CCC) · Via ACCESS Newswire · June 22, 2026
Breakthrough Study in Cell Paves Way for ROCK2-Targeted Therapy TDI01 in Liver Fibrosis
By Cloud-Clone Corp. (CCC) · Via ACCESS Newswire · June 16, 2026